There has been a lot of progress with gene editing to precisely engineer the genome. We are close to starting to fix major gene-related diseases like sickle cell anemia. Preclinical studies using gene editing to tackle genetic and infectious diseases have highlighted the therapeutic potential of this technology. How close are we to using gene editing tools for the treatment of haematological (blood) disorders and the hurdles that need to be overcome to achieve clinical success.
There remain major barriers associated with the editing-based therapeutic treatment of blood disorders that must be addressed to advance clinical applications that rely on genome editing. Some of these challenges include :
1. the delivery of the editing machinery ex vivo (outside) and in vivo (inside the body)
2. the ability to preserve the stemness and achieve high levels of engraftment of HSCs in vivo
3. the identification and reduction in genome-wide off-target effects induced by the nucleases.
Emerging Topics in Life Science – Genome editing for blood disorders: state of the art and recent advances
SOURCES : Emerging Topics in Life Science
Wang is a prolific business-oriented writer of emerging and disruptive technologies. He is known for insightful articles that combine business and technical analysis that catches the attention of the general public and is also useful for those in the industries. He is the sole author and writer of nextbigfuture.com
, the top online science blog. He is also involved in angel investing and raising funds for breakthrough technology startup companies.
He gave the recent keynote presentation at Monte Jade event with a talk entitled the Future for You. He gave an annual update on molecular nanotechnology at Singularity University on nanotechnology, gave a TEDX talk on energy, and advises USC ASTE 527 (advanced space projects program). He has been interviewed for radio, professional organizations. podcasts and corporate events. He was recently interviewed by the radio program Steel on Steel on satellites and high altitude balloons that will track all movement in many parts of the USA.
He fundraises for various high impact technology companies and has worked in computer technology, insurance, healthcare and with corporate finance.
He has substantial familiarity with a broad range of breakthrough technologies like age reversal and antiaging, quantum computers, artificial intelligence, ocean tech, agtech, nuclear fission, advanced nuclear fission, space propulsion, satellites, imaging, molecular nanotechnology, biotechnology, medicine, blockchain, crypto and many other areas.